These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33087380)

  • 1. IMAGINE Network's
    Moayyedi P; MacQueen G; Bernstein CN; Vanner S; Bercik P; Madsen KL; Surette M; Rioux JD; Dieleman LA; Verdú E; de Souza RJ; Otley A; Targownik L; Lavis J; Cunningham J; Marshall DA; Zelinsky S; Fernandes A
    BMJ Open; 2020 Oct; 10(10):e041733. PubMed ID: 33087380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
    Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
    Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does symptom activity explain psychological differences in patients with irritable bowel syndrome and inflammatory bowel disease? Results from a multi-center cross-sectional study.
    Berens S; Schaefert R; Baumeister D; Gauss A; Eich W; Tesarz J
    J Psychosom Res; 2019 Nov; 126():109836. PubMed ID: 31627144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I am doing the best that I can!: Living with inflammatory bowel disease and/or irritable bowel syndrome (part II).
    Fletcher PC; Schneider MA; Van Ravenswaay V; Leon Z
    Clin Nurse Spec; 2008; 22(6):278-85. PubMed ID: 18955845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
    Lopetuso LR; Petito V; Graziani C; Schiavoni E; Paroni Sterbini F; Poscia A; Gaetani E; Franceschi F; Cammarota G; Sanguinetti M; Masucci L; Scaldaferri F; Gasbarrini A
    Dig Dis; 2018; 36(1):56-65. PubMed ID: 28683448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bugs and Brains, the Gut and Mental Health Study: a mixed-methods study investigating microbiota composition and function in anxiety, depression and irritable bowel syndrome.
    Simpson CA; Schwartz OS; Eliby D; Butler CA; Huang K; O'Brien-Simpson N; Callaghan BL; Dashper SG; Gooley PR; Whittle S; Haslam N; Simmons JG
    BMJ Open; 2021 Mar; 11(3):e043221. PubMed ID: 33722869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.
    Vich Vila A; Imhann F; Collij V; Jankipersadsing SA; Gurry T; Mujagic Z; Kurilshikov A; Bonder MJ; Jiang X; Tigchelaar EF; Dekens J; Peters V; Voskuil MD; Visschedijk MC; van Dullemen HM; Keszthelyi D; Swertz MA; Franke L; Alberts R; Festen EAM; Dijkstra G; Masclee AAM; Hofker MH; Xavier RJ; Alm EJ; Fu J; Wijmenga C; Jonkers DMAE; Zhernakova A; Weersma RK
    Sci Transl Med; 2018 Dec; 10(472):. PubMed ID: 30567928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
    Gracie DJ; Hamlin JP; Ford AC
    Am J Gastroenterol; 2018 May; 113(5):702-712. PubMed ID: 29453384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of self-perceived health status in inflammatory bowel disease and irritable bowel syndrome patients from a Canadian national population survey.
    Tang LY; Nabalamba A; Graff LA; Bernstein CN
    Can J Gastroenterol; 2008 May; 22(5):475-83. PubMed ID: 18478133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
    Szilagyi A; Xue X
    Med Hypotheses; 2018 Jan; 110():31-37. PubMed ID: 29317064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.
    Maagaard L; Ankersen DV; Végh Z; Burisch J; Jensen L; Pedersen N; Munkholm P
    World J Gastroenterol; 2016 Apr; 22(15):4009-19. PubMed ID: 27099444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome.
    Guadagnoli L; Mutlu EA; Doerfler B; Ibrahim A; Brenner D; Taft TH
    Qual Life Res; 2019 Aug; 28(8):2195-2205. PubMed ID: 30900206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment.
    Gracie DJ; Hamlin PJ; Ford AC
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):632-642. PubMed ID: 31122802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Shutkever O; Gracie DJ; Young C; Wood HM; Taylor M; John Hamlin P; Ford AC; Quirke P
    Inflamm Bowel Dis; 2018 Jun; 24(7):1597-1605. PubMed ID: 29668957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study.
    Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G
    BMJ Open; 2021 Feb; 11(2):e042493. PubMed ID: 33593778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
    Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
    Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome composition and risk factors in a large cross-sectional IBS cohort.
    Agnello M; Carroll LN; Imam N; Pino R; Palmer C; Varas I; Greene C; Hitschfeld M; Gupta S; Almonacid DE; Hoaglin MC
    BMJ Open Gastroenterol; 2020; 7(1):e000345. PubMed ID: 32518661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.